AstraZeneca announced that the COVID-19 vaccine trial has resumed in the United States, including at UW Health and the UW School of Medicine and Public Health, after the FDA and an independent safety review board completed their review of an illness contracted by a trial participant in the United Kingdom....
Just a handful of volunteers received their first doses of AstraZeneca's Covid-19 vaccine candidate before the trial was put on hold and causing researchers to essentially start from scratch....
Even if ultimately approved and proven effective, there won't be enough of the medications for everyone who needs them....
A Q+A about COVID-19 and the All of Us Research Program with Dr. Ed Ramos, the Director of the Digital Clinical Trials at Scripps Research institute. ...
Dr. Dipesh Navsaria, a UW Health physician, discusses why he chose to volunteer for a COVID-19 vaccine clinical trial at UW Health....
At least 10 COVID-19 vaccines are currently in the final phase of their trials, where the vaccine is given to thousands of people to test its safety and efficacy. But as the quest for a coronavirus vaccine continues, experts say there’s still an issue with how diverse these trials are, which could impact how effective a vaccine is for everyone....
As the Food and Drug Administration and Centers for Disease Control and Prevention repeatedly assure the public that the COVID-19 vaccine will be safe, indications that the review process may be undercut by politics has turned off people in minority communities to getting the vaccine when it becomes available — worrying physicians that communities disproportionately devastated by the pandemic are most at risk of being left out of immunization efforts....
Many thousands of volunteers from minority groups are needed for huge clinical trials underway or about to begin. Scientists say a diverse group of test subjects is vital to determining whether a vaccine is safe and effective for everyone and instilling broad public confidence in the shots once they become available....
A new effort at the National Institutes of Health (NIH) gives people the opportunity to take part in clinical trials. ...
As UW Health and the University of Wisconsin begin scheduling participants for the AstraZeneca COVID-19 vaccine study, experts and leaders are focused on equity and inclusion to ensure a diverse population takes part in this phase 3 clinical trial. A diverse group of participants will give researchers the best understanding on how and if this vaccine works for everyone....